CDKN2A and cardiomyopathy: Our recent studies have demonstrated that reducing SLN expression is sufficient to restore cardiac SERCA function and Cai2+ cycling and to prevent the development of cardiomyopathy in mdx mice throughout their lifespan (Mareedu et al., 2021).